Page last updated: 2024-08-25

oxazolidin-2-one and Nausea

oxazolidin-2-one has been researched along with Nausea in 11 studies

Research

Studies (11)

Timeframe	Studies, this research(%)	All Research%
pre-1990	1 (9.09)	18.7374
1990's	3 (27.27)	18.2507
2000's	5 (45.45)	29.6817
2010's	2 (18.18)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Dodick, DW; Friedman, DI; Gelfand, AA; Kellerman, DJ; Schmidt, PC; Tepper, SJ	1
Dodick, DW; Kellerman, DJ; Schmidt, PC; Tepper, SJ	1
FATHIE, K	1
Dahlöf, C	1
Igarashi, H	1
Emeribe, U; Hee, A; Silberstein, S; Tuchman, M	1
Diener, HC; Evers, S	1
Sawyer, J; Schoenen, J	1
Cleary, EW; Huffman, CS; Polvino, WJ; Smith, DA; Watkins, S	1
Prusiński, A	1
Goadsby, PJ; Jiang, K; Lines, CR; Lipton, RB; Massiou, H; McCarroll, KA; Pascual, J; Vandormael, K	1

Reviews

3 review(s) available for oxazolidin-2-one and Nausea

Article	Year
Clinical applications of new therapeutic deliveries in migraine. Neurology, 2003, Oct-28, Volume: 61, Issue:8 Suppl 4 Topics: Administration, Intranasal; Administration, Oral; Adult; Clinical Trials as Topic; Dysgeusia; Female; Humans; Injections, Subcutaneous; Male; Middle Aged; Migraine Disorders; Nausea; Oxazolidinones; Serotonin Receptor Agonists; Sumatriptan; Tablets; Tryptamines; Vasoconstrictor Agents	2003
[Side effects of triptans]. No to shinkei = Brain and nerve, 2004, Volume: 56, Issue:9 Topics: Central Nervous System; Dose-Response Relationship, Drug; Humans; Indoles; Migraine Disorders; Nausea; Oxazolidinones; Pyrrolidines; Receptor, Serotonin, 5-HT1D; Serotonin Receptor Agonists; Sleep Stages; Sumatriptan; Triazoles; Tryptamines; Vomiting	2004
[Emergency treatment of migraine attacks with particular reference to agonists of 5-HT1B/1D receptor]. Neurologia i neurochirurgia polska, 1999, Volume: 32 Suppl 6 Topics: Analgesics; Anti-Inflammatory Agents, Non-Steroidal; Biological Availability; Emergency Treatment; Ergotamine; Humans; Migraine Disorders; Nausea; Oxazolidinones; Serotonin Receptor Agonists; Sumatriptan; Tryptamines	1999

Trials

6 trial(s) available for oxazolidin-2-one and Nausea

Article	Year
Use of Most Bothersome Symptom as a Coprimary Endpoint in Migraine Clinical Trials: A Post-Hoc Analysis of the Pivotal ZOTRIP Randomized, Controlled Trial. Headache, 2018, Volume: 58, Issue:7 Topics: Adult; Biomarkers; Double-Blind Method; Humans; Hyperacusis; Injections, Intradermal; Migraine Disorders; Nausea; Outcome Assessment, Health Care; Oxazolidinones; Photophobia; Serotonin 5-HT1 Receptor Agonists; Tryptamines	2018
Efficacy of ADAM Zolmitriptan for the Acute Treatment of Difficult-to-Treat Migraine Headaches. Headache, 2019, Volume: 59, Issue:4 Topics: Adult; Double-Blind Method; Female; Humans; Injections, Intradermal; Male; Middle Aged; Migraine Disorders; Nausea; Outcome Assessment, Health Care; Oxazolidinones; Pain Measurement; Serotonin 5-HT1 Receptor Agonists; Time Factors; Time-to-Treatment; Tryptamines	2019
Efficacy and tolerability of zolmitriptan oral tablet in the acute treatment of menstrual migraine. CNS drugs, 2006, Volume: 20, Issue:12 Topics: Acute Disease; Administration, Oral; Adult; Chest Pain; Dizziness; Double-Blind Method; Female; Humans; Menstruation Disturbances; Middle Aged; Migraine Disorders; Nausea; Oxazolidinones; Paresthesia; Patient Dropouts; Self Administration; Serotonin Receptor Agonists; Tablets; Treatment Outcome; Tryptamines	2006
Effectiveness and satisfaction with zolmitriptan 5 mg nasal spray for treatment of migraine in real-life practice: results of a postmarketing surveillance study. Clinical drug investigation, 2007, Volume: 27, Issue:1 Topics: Administration, Intranasal; Adult; Adverse Drug Reaction Reporting Systems; Cardiovascular Diseases; Dizziness; Female; Humans; Male; Middle Aged; Migraine with Aura; Migraine without Aura; Nausea; Oxazolidinones; Patient Satisfaction; Product Surveillance, Postmarketing; Serotonin Receptor Agonists; Surveys and Questionnaires; Treatment Outcome; Tryptamines	2007
Zolmitriptan (Zomig, 311C90), a novel dual central and peripheral 5HT1B/1D agonist: an overview of efficacy. Cephalalgia : an international journal of headache, 1997, Volume: 17 Suppl 18 Topics: Adolescent; Adult; Aged; Child; Dose-Response Relationship, Drug; Female; Humans; Menstruation; Middle Aged; Migraine Disorders; Nausea; Oxazoles; Oxazolidinones; Recurrence; Serotonin Receptor Agonists; Sumatriptan; Treatment Outcome; Tryptamines	1997
Zolmitriptan (311C90) does not interact with fluoxetine in healthy volunteers. International journal of clinical pharmacology and therapeutics, 1998, Volume: 36, Issue:6 Topics: Adolescent; Adult; Cranial Sinuses; Cross-Over Studies; Dizziness; Drug Interactions; Drug Tolerance; Female; Fluoxetine; Humans; Intracranial Pressure; Male; Middle Aged; Nausea; Oxazoles; Oxazolidinones; Patient Compliance; Pharyngitis; Selective Serotonin Reuptake Inhibitors; Serotonin Receptor Agonists; Tryptamines	1998

Other Studies

2 other study(ies) available for oxazolidin-2-one and Nausea

Article	Year
A SECOND LOOK AT A SKELETAL MUSCLE RELAXANT: A DOUBLE-BLIND STUDY OF METAXALONE. Current therapeutic research, clinical and experimental, 1964, Volume: 6 Topics: Anticonvulsants; Back Pain; Biomedical Research; Double-Blind Method; Drug Therapy; Humans; Muscle Relaxants, Central; Nausea; Neuromuscular Agents; Oxazolidinones; Placebos; Polyuria; Spasm; Toxicology; Vertigo	1964
Effect of rizatriptan and other triptans on the nausea symptom of migraine: a post hoc analysis. Headache, 2001, Volume: 41, Issue:8 Topics: Administration, Oral; Adult; Double-Blind Method; Humans; Indoles; Migraine Disorders; Nausea; Oxazolidinones; Piperidines; Randomized Controlled Trials as Topic; Serotonin Receptor Agonists; Sumatriptan; Triazoles; Tryptamines; Vasoconstrictor Agents	2001